AI Summary
StalkPrice is extended well above the 9/21 EMAs into overbought territory, with RSI and Options Score at extreme levels signaling near-term exhaustion. The medium-term structure remains bullish in a Stage 2 advancing regime, but timing is unfavorable for new entries. Deferred engagement on a pullback into rising short-term EMAs offers a more favorable entry. Primary risks include a sharp reversal if the EMAs fail to hold and exhaustion of the current breakout.